Trial Site Detail

 

Drug:
Nilotinib
Trial:
Efficacy and Safety of AMN107 Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib - Extension
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Washington Cancer Institute

110 Irving St     
Washington , DC 20010
USA

 

Principal Investigator:
Contact:
Jake Paterson, 202 877-5371
Activation Status of this Site:
Closed
Notes about this Site:
Washington Cancer Institute Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.